Secret of the major birch pollen allergen Bet v 1: identification of the physiological ligand

被引:77
|
作者
Seutter von Loetzen, Christian [1 ,2 ]
Hoffmann, Thomas [3 ]
Hartl, Maximilian J. [1 ,2 ]
Schweimer, Kristian [1 ,2 ]
Schwab, Wilfried [3 ]
Roesch, Paul [1 ,2 ]
Hartl-Spiegelhauer, Olivia [1 ,2 ]
机构
[1] Univ Bayreuth, Lehrstuhl Biopolymere, D-95447 Bayreuth, Germany
[2] Univ Bayreuth, Forschungszentrum Biomakromol, D-95447 Bayreuth, Germany
[3] Tech Univ Munich, D-85354 Freising Weihenstephan, Germany
关键词
allergen; Bet v 1; NMR; quercetin-3-O-sophoroside (Q3OS); PATHOGENESIS-RELATED PROTEINS; LECTIN-CARBOHYDRATE INTERACTIONS; FLAVONOL; 3-O-GALACTOSYLTRANSFERASE; BIOLOGICAL FUNCTION; CROSS-REACTIVITY; IGE REACTIVITY; FOOD ALLERGENS; IN-VITRO; X-RAY; BET-V-1;
D O I
10.1042/BJ20130413
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The major birch pollen allergen Bet v 1 is the main elicitor of airborne type I allergies and belongs to the PR-10 family (pathogenesis-related proteins 10). Bet v 1 is the most extensively studied allergen, and is well characterized at a biochemical and immunological level; however, its physiological function remains elusive. In the present study, we identify Q3OS (quercetin-3-O-sophoroside) as the natural ligand of Bet v 1. We isolated Q3OS bound to Bet v 1 from mature birch pollen and confirmed its binding by reconstitution of the Bet v 1-Q3OS complex. Fluorescence and UV visible spectroscopy experiments, as well as HSQC (heteronuclear single-quantum coherence) titration, and the comparison with model compounds, such as quercetin, indicated the specificity of Q3OS binding. Elucidation of the binding site by NMR combined with a computational model resulted in a more detailed understanding and shed light on the physiological function of Bet v 1. We postulate that the binding of Q3OS to Bet v 1 plays an important, but as yet unclear, role during the inflammation response and Bet v 1 recognition by IgE.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 50 条
  • [41] Profiling recombinant major birch pollen allergen Bet v 1a and carbamylated variants with CZE and CIEF
    Kronsteiner, Barbara
    Malissa, Hans, Jr.
    Stutz, Hanno
    ELECTROPHORESIS, 2007, 28 (13) : 2241 - 2251
  • [42] Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its biological function
    Markovic-Housley, Z
    Degano, M
    Lamba, D
    Susani, M
    Ferreira, F
    Scheiner, O
    Breiteneder, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S164 - S164
  • [43] Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
    Vrtala, Susanne
    Fohr, Monika
    Campana, Raffaela
    Baumgartner, Christian
    Valent, Peter
    Valenta, Rudolf
    VACCINE, 2011, 29 (11) : 2140 - 2148
  • [44] Harmonization of the Genetic Code Effectively Enhances the Recombinant Production of the Major Birch Pollen Allergen Bet v 1
    Asam, Claudia
    Roulias, Anargyros
    Parigiani, Maria A.
    Haab, Astrid
    Wallner, Michael
    Wolf, Martin
    Briza, Peter
    Bohle, Barbara
    Ferreira, Fatima
    Hauser, Michael
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2018, 177 (02) : 116 - 122
  • [45] In vitro and in vivo characterization of vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1
    Mahler, V
    Vrtala, S
    Kuss, O
    Diepgen, TL
    Cromwell, O
    Fiebeg, H
    Schuler, G
    Kraft, D
    Valenta, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S255 - S255
  • [46] Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1
    Gafvelin, G
    Thunberg, S
    Kronqvist, M
    Grönlund, H
    Grönneberg, R
    Troye-Blomberg, M
    Akdis, M
    Fiebig, H
    Purohit, A
    Horak, F
    Reisinger, J
    Niederberger, V
    Akdis, CA
    Cromwell, O
    Pauli, G
    Valenta, R
    van Hage, M
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2005, 138 (01) : 59 - 66
  • [47] Recombinant Bet v 1, the major birch pollen allergen, induces hypersensitivity reactions equal to those induced by natural Bet v 1 in the airways of patients allergic to tree pollen
    GodnicCvar, J
    Susani, M
    Breiteneder, H
    Berger, A
    Havelec, L
    Waldhor, T
    Hirschwehr, R
    Valenta, R
    Scheiner, O
    Rudiger, H
    Kraft, D
    Ebner, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (03) : 354 - 359
  • [48] Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen
    Son, DY
    Scheurer, S
    Hoffmann, A
    Haustein, D
    Vieths, S
    EUROPEAN JOURNAL OF NUTRITION, 1999, 38 (04) : 201 - 215
  • [49] Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen
    D.Y. Son
    S. Scheurer
    A. Hoffmann
    D. Haustein
    S. Vieths
    European Journal of Nutrition, 1999, 38 : 201 - 215
  • [50] Mapping of IgG-binding epitopes on major birch pollen allergen Bet v 1 for identification of hypoallergenic peptides with potential therapeutic application
    Sosic, L.
    Paolucci, M.
    Melillo, D.
    Duda, A.
    Wackerle-Men, Y.
    Streuli, A.
    Eyer, K.
    Kundig, T.
    Johansen, P.
    SWISS MEDICAL WEEKLY, 2023, 153 : 15S - 15S